A Double-Blind Study of Zaltoprofen for the Treatment of Upper Respiratory Tract Infection

Publisher： Karger

E-ISSN： 1423-0313|85|1|41-47

ISSN： 0031-7012

Source： Pharmacology, Vol.85, Iss.1, 2009-12, pp. : 41-47

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Antipyretic and Analgesic Effects of Zaltoprofen for the Treatment of Acute Upper Respiratory Tract Infection: Verification of a Noninferiority Hypothesis Using Loxoprofen Sodium

By  

Pharmacology, Vol. 87, Iss. 3-4, 2011-03 ,pp. : 204-213

Karger

Access to resources Recommend Favorite

Prulifloxacin versus Levofloxacin in the Treatment of Respiratory and Urinary Tract Infections: A Multicentre, Double-Blind, Randomized Controlled Clinical Trial

By  

Chemotherapy, Vol. 58, Iss. 3, 2012-08 ,pp. : 249-256

Karger

Access to resources Recommend Favorite

Cefixime in the Treatment of Upper Respiratory Tract Infections and Otitis media

By  

Chemotherapy, Vol. 44, Iss. 1, 1998-10 ,pp. : 19-23

Karger

Access to resources Recommend Favorite

Treatment of Head and Neck Dermatitis with Ciclopiroxolamine Cream – Results of a Double-Blind, Placebo-Controlled Study

By  

Skin Pharmacology and Physiology, Vol. 19, Iss. 3, 2006-06 ,pp. : 153-158

Karger

Access to resources Recommend Favorite

Beneficial Long-Term Effects of Combined Oral/Topical Antioxidant Treatment with the Carotenoids Lutein and Zeaxanthin on Human Skin: A Double-Blind, Placebo-Controlled Study

By  

Skin Pharmacology and Physiology, Vol. 20, Iss. 4, 2007-04 ,pp. : 199-210

Karger

Access to resources Recommend Favorite